Eli Lilly’s weight-loss drug tirzepatide, sold as Mounjaro and Zepbound, is no longer in shortage in the US, according to the FDA. The drugmaker has resolved the shortage by increasing production and working to meet demand, along with rival drugmaker Novo Nordisk. The market for these drugs is expected to grow significantly, prompting both companies to expand production and invest in new facilities.
Full Article
How Entrepreneurs Automate Time-Consuming Tasks With the Latest AI
Entrepreneur is featuring products and services that can help entrepreneurs automate tasks and save time during the business development process. Through 1minAI's AI models like ChatGPT and Gemini, founders can streamline responsibilities like writing emails and coding websites. Additionally, entrepreneurs can enhance their social media presence and receive assistance with SEO practices through AI chatbots, creating a robust online footprint. The lifetime subscription to 1minAI is currently available for only $29.97, offering a valuable resource...
Read more